Clinical Trial Update: Comparison of Diagnostic Accuracy Between XTR004 PET MPI and the Composite Index of Quantitative Coronary Angiography (QCA) and Fractional Flow Reserve (FFR) [Phase 3]

View source ↗

Summary

The document describes a Phase 3 clinical trial comparing XTR004 PET MPI to a composite index of QCA and FFR for diagnostic accuracy in coronary artery disease,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• XTR004

Snippet

Sponsor: Sinotau Pharmaceutical Group | Conditions: Coronary Artery Disease(CAD) | Phase 3 | Status: RECRUITING